Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BOSTON BEER CO INCSAM · Entity 4577 | Director | May 27, 2026 | May 28, 2026 |
| Oscar Health, Inc.OSCR · Entity 3582 | Chief Operating Officer | March 01, 2022 | March 03, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BOSTON BEER CO INC
Report date May 27, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A CommonSEC Table I · non-derivative | Direct | 1,076 |
Reported balance
After 2026-05-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-27 · Grant · Acquired 358 · Balance 1,076 F1: On May 27, 2026, the Issuer granted 358 RSUs to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The shares will vest in full on May 12, 2027, provided that the non-employee Director remains a member of the Board of Directors as of that date. F2: The shares reported include 358 shares of restricted stock subject to vesting conditions. |
| May 27, 2026 Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $181.63 · Expires 2036-05-26 | Direct | 691 |
Reported balance
After 2026-05-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-27 · Grant · Acquired 691 · Balance 691 F3: On May 27, 2026, the Issuer granted 691 option shares to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The option shares are immediately exercisable, subject to the Company's Director Stock Ownership and Retention Guidelines. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 27, 2026, the Issuer granted 358 RSUs to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The shares will vest in full on May 12, 2027, provided that the non-employee Director remains a member of the Board of Directors as of that date.
F2: The shares reported include 358 shares of restricted stock subject to vesting conditions.
F3: On May 27, 2026, the Issuer granted 691 option shares to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The option shares are immediately exercisable, subject to the Company's Director Stock Ownership and Retention Guidelines.
Oscar Health, Inc.
Report date March 01, 2022 · Filed March 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 43,070 |
Ending reported balance
After 2022-03-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-03-01 · Exercise / conversion · Acquired 7,016 · Balance 45,610 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 2 · 2022-03-02 · Sale · Disposed 2,540 · Balance 43,070 F2: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9105 to $6.915, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 98,220 |
Reported balance
After 2022-03-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-03-01 · Exercise / conversion · Disposed 7,016 · Balance 98,220 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Spouse | 15,896 |
Reported balance
Holding disclosure · report date 2022-03-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 15,896 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9105 to $6.915, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F4: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Guardant Health, Inc.
Report date June 17, 2026 · Filed June 22, 2026
Section 16 reporting ended · disclosed 2026-06-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,386 |
Reported balance
After 2026-06-17 transaction · row 1
1 source rowRow 1 · 2026-06-17 · Exercise / conversion · Acquired 4,203 · Balance 15,386 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-06-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-17 · Exercise / conversion · Disposed 4,203 · Balance 0 F1: The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026. F2: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026.
F2: Not applicable for Restricted Stock Units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2026 Filed Jun 22, 2026 21:53 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 4,203 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001770749-26-000005 · wk-form4_1782165177.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,203 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 21:53 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 4,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001770749-26-000005 · wk-form4_1782165177.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 22:07 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,803 | $0.00 Strike: $38.01 | $0.00 |
DisclosureSEC source: 0001770749-26-000003 · wk-form4_1780610835.xml · derivative · entry 8 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,803 shares Expires 2033-06-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock option award vested in full on June 12, 2024. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 22:07 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,197 | $0.00 Strike: $38.42 | $0.00 |
DisclosureSEC source: 0001770749-26-000003 · wk-form4_1780610835.xml · derivative · entry 7 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,908 Underlying: Common Stock · 1,197 shares Expires 2032-06-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option award vested in full on June 14, 2023. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 22:07 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 106 | $129.31 | $13,706.98 |
DisclosureSEC source: 0001770749-26-000003 · wk-form4_1780610835.xml · nonDerivative · entry 6 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,183 F4 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $129.28 to $129.83. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 22:07 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 650 | $128.02 | $83,212.74 |
DisclosureSEC source: 0001770749-26-000003 · wk-form4_1780610835.xml · nonDerivative · entry 5 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,289 F3 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $127.92 to $128.24. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 22:07 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 5,728 | $127.11 | $728,059.73 |
DisclosureSEC source: 0001770749-26-000003 · wk-form4_1780610835.xml · nonDerivative · entry 4 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,939 F2 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $126.815 to $127.75. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 22:07 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 3,516 | $126.52 | $444,829.20 |
DisclosureSEC source: 0001770749-26-000003 · wk-form4_1780610835.xml · nonDerivative · entry 3 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,667 F1 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $125.80 to $126.785. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 22:07 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 8,803 | $38.01 | $334,558.02 |
DisclosureSEC source: 0001770749-26-000003 · wk-form4_1780610835.xml · nonDerivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 22:07 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,197 | $38.42 | $45,988.74 |
DisclosureSEC source: 0001770749-26-000003 · wk-form4_1780610835.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,380 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2026 Filed May 28, 2026 11:47 UTC | BOSTON BEER CO INC SAM · Entity 4577 | GrantMay 27, 2026 Stock Option · Derivative | 691 | $0.00 Strike: $181.63 | $0.00 |
DisclosureSEC source: 0001770749-26-000001 · primarydocument.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 691 Underlying: Class A Common · 691 shares Expires 2036-05-26 F3 · kind: On May 27, 2026, the Issuer granted 691 option shares to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The option shares are immediately exercisable, subject to the Company's Director Stock Ownership and Retention Guidelines. Read SEC document |
| May 27, 2026 Filed May 28, 2026 11:47 UTC | BOSTON BEER CO INC SAM · Entity 4577 | GrantClass A Common | 358 | $0.00 | $0.00 |
DisclosureSEC source: 0001770749-26-000001 · primarydocument.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,076 F1 · kind: On May 27, 2026, the Issuer granted 358 RSUs to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The shares will vest in full on May 12, 2027, provided that the non-employee Director remains a member of the Board of Directors as of that date. F2 · balance_after: The shares reported include 358 shares of restricted stock subject to vesting conditions. Read SEC document |
| September 02, 2025 Filed Sep 3, 2025 22:50 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 100 | $65.84 | $6,584.00 |
DisclosureSEC source: 0001770749-25-000003 · wk-form4_1756939806.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,183 Read SEC document |
| August 04, 2025 Filed Aug 6, 2025 20:57 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 67 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000252 · wk-form4_1754513832.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 67 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vested as to 25% of the shares subject to such award on August 4, 2022. The remaining 75% of the shares subject to such award vests in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| August 04, 2025 Filed Aug 6, 2025 20:57 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 67 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000252 · wk-form4_1754513832.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 04, 2025 Filed Jul 7, 2025 20:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 66 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000227 · wk-form4_1751921032.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67 Underlying: Common Stock · 66 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vested 25% of the shares subject to such award on August 4, 2022. The remaining 75% of the shares subject to such award vests in substantially equal installments on each monthly anniversary of August 4, 2022 during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 04, 2025 Filed Jul 7, 2025 20:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 66 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000227 · wk-form4_1751921032.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 21:36 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 4,203 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000199 · wk-form4_1750455368.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,203 Underlying: Common Stock · 4,203 shares Expires not disclosed F2 · derivative.exercise_date: The restricted stock units vest in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 21:36 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantStock Option (Right to Buy) · Derivative | 6,833 | $0.00 Strike: $50.57 | $0.00 |
DisclosureSEC source: 0001576280-25-000199 · wk-form4_1750455368.xml · derivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,833 Underlying: Common Stock · 6,833 shares Expires 2035-06-18 F1 · derivative.exercise_date: The stock option vests in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 23:27 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 3,337 | $47.22 | $157,573.14 |
DisclosureSEC source: 0001576280-25-000179 · wk-form4_1750116434.xml · nonDerivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,150 Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 23:27 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 6,674 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000179 · wk-form4_1750116434.xml · derivative · entry 3 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,674 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vest in full on the one-year anniversary of the grant date, June 12, 2024 or the date of the next year annual stockholders meeting, whichever is earlier. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 23:27 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 6,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000179 · wk-form4_1750116434.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,487 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 23:14 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 67 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000167 · wk-form4_1749165052.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133 Underlying: Common Stock · 67 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vested 25% of the shares subject to such award on August 4, 2022. The remaining 75% of the shares subject to such award vests in substantially equal installments on each monthly anniversary of August 4, 2022 during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 23:14 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 67 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000167 · wk-form4_1749165052.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,813 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 21:49 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 100 | $41.66 | $4,166.00 |
DisclosureSEC source: 0001576280-25-000163 · wk-form4_1748987374.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,746 Read SEC document |
| May 14, 2025 Filed May 15, 2025 13:20 UTC | BOSTON BEER CO INC SAM · Entity 4577 | GrantMay 14, 2025 Stock Option · Derivative | 546 | $0.00 Strike: $240.26 | $0.00 |
DisclosureSEC source: 0001562180-25-003853 · primarydocument.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 546 Underlying: Class A Common · 546 shares Expires 2035-05-13 F3 · kind: On May 14, 2025, the Issuer granted 546 option shares to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The option shares are immediately exercisable, subject to the Company's Director Stock Ownership and Retention Guidelines. Read SEC document |
| May 14, 2025 Filed May 15, 2025 13:20 UTC | BOSTON BEER CO INC SAM · Entity 4577 | GrantClass A Common | 271 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-003853 · primarydocument.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 718 F1 · kind: On May 14, 2025, the Issuer granted 271 RSUs to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The shares will vest in full on May 13, 2026, provided that the non-employee Director remains a member of the Board of Directors as of that date. F2 · balance_after: The shares reported include 271 shares of restricted stock subject to vesting conditions. Read SEC document |
| May 04, 2025 Filed May 6, 2025 01:03 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 66 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000143 · wk-form4_1746493379.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200 Underlying: Common Stock · 66 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vested as to 25% of the shares subject to such award on August 4, 2022 and the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022 during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| May 04, 2025 Filed May 6, 2025 01:03 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 66 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000143 · wk-form4_1746493379.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2025 Filed Apr 7, 2025 21:31 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 66 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000122 · wk-form4_1744061494.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 266 Underlying: Common Stock · 66 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vested as to 25% of the shares subject to such award on August 4, 2022, and the remaining 75% of the shares subject to such award vest in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 04, 2025 Filed Apr 7, 2025 21:31 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 66 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000122 · wk-form4_1744061494.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:48 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 67 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000064 · wk-form4_1741211287.xml · derivative · entry 3 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 332 Underlying: Common Stock · 67 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vested as to 25% of the shares subject to the award on August 4, 2022, and the remaining 75% of the shares subject to such award vests in substantially equal installments on each monthly anniversary of August 4, 2022 during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:48 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 67 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000064 · wk-form4_1741211287.xml · nonDerivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:48 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 100 | $42.71 | $4,271.00 |
DisclosureSEC source: 0001576280-25-000064 · wk-form4_1741211287.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,647 Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 21:33 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 66 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000038 · wk-form4_1738791227.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 399 Underlying: Common Stock · 66 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vested as to 25% of the shares subject to such award on August 4, 2022, and as the remaining 75% of the shares vest in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 21:33 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 66 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000038 · wk-form4_1738791227.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2025 Filed Jan 6, 2025 23:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 66 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000020 · wk-form4_1736205938.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 465 Underlying: Common Stock · 66 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vested as to 25% of the shares subject to such award on August 4, 2022, and the remaining 75% of the shares subject to such award vests in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 04, 2025 Filed Jan 6, 2025 23:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 66 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000020 · wk-form4_1736205938.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,681 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 23:42 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 67 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000299 · wk-form4_1733442129.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 531 Underlying: Common Stock · 67 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vested as to 25% of the shares subject to such award on August 4, 2022, and the remaining 75% of the shares subject to such award vest in substantially equal installments on each monthly anniversary of August 4, 2022 during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 23:42 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 67 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000299 · wk-form4_1733442129.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,615 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 00:00 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 100 | $35.90 | $3,590.00 |
DisclosureSEC source: 0001576280-24-000297 · wk-form4_1733270393.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,548 Read SEC document |
| November 13, 2024 Filed Nov 14, 2024 22:59 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 2,896 | $29.90 | $86,595.32 |
DisclosureSEC source: 0001576280-24-000281 · wk-form4_1731625183.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,648 F1 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $29.52 to $29.95. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 04, 2024 Filed Nov 5, 2024 21:37 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 66 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000257 · wk-form4_1730842651.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 598 Underlying: Common Stock · 66 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on August 4, 2022, and as the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| November 04, 2024 Filed Nov 5, 2024 21:37 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 66 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000257 · wk-form4_1730842651.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,544 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2024 Filed Oct 7, 2024 21:22 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 66 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000245 · wk-form4_1728336122.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 664 Underlying: Common Stock · 66 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on August 4, 2022, and as the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 04, 2024 Filed Oct 7, 2024 21:22 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 66 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000245 · wk-form4_1728336122.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2024 Filed Sep 5, 2024 20:52 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 67 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000204 · wk-form4_1725569546.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 730 Underlying: Common Stock · 67 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on August 4, 2022, and as the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 04, 2024 Filed Sep 5, 2024 20:52 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 67 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000204 · wk-form4_1725569546.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2024 Filed Aug 5, 2024 22:10 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 66 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000186 · wk-form4_1722895810.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 797 Underlying: Common Stock · 66 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on August 4, 2022, and as the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| August 04, 2024 Filed Aug 5, 2024 22:10 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 66 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000186 · wk-form4_1722895810.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,345 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.